Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scienture Holdings (SCNX) Common Equity (2016 - 2025)

Scienture Holdings (SCNX) has disclosed Common Equity for 13 consecutive years, with $70.1 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 11.32% to $70.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $70.1 million through Dec 2025, down 11.32% year-over-year, with the annual reading at $70.1 million for FY2025, 11.32% down from the prior year.
  • Common Equity hit $70.1 million in Q4 2025 for Scienture Holdings, down from $77.9 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $81.2 million in Q1 2025 to a low of -$1.3 million in Q2 2023.
  • Historically, Common Equity has averaged $20.8 million across 5 years, with a median of $5.2 million in 2021.
  • Biggest five-year swings in Common Equity: tumbled 171.74% in 2023 and later surged 14479.46% in 2024.
  • Year by year, Common Equity stood at $3.8 million in 2021, then crashed by 90.91% to $342867.0 in 2022, then soared by 58.18% to $542353.0 in 2023, then soared by 14479.46% to $79.1 million in 2024, then dropped by 11.32% to $70.1 million in 2025.
  • Business Quant data shows Common Equity for SCNX at $70.1 million in Q4 2025, $77.9 million in Q2 2025, and $81.2 million in Q1 2025.